These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11980332)

  • 21. Response of falciparum malaria to chloroquine and three second line antimalarial drugs in a Kenyan coastal school age population.
    Hagos B; Khan B; Ofulla AV; Kariuki D; Martin SK
    East Afr Med J; 1993 Oct; 70(10):620-3. PubMed ID: 8187656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response of Plasmodium falciparum to chloroquine and Fansidar in vivo and chloroquine and amodiaquine in vitro in Uganda.
    Nevill CG; Ochen K; Munafu CG; Bekobita D; Sezi CL
    East Afr Med J; 1995 Jun; 72(6):349-54. PubMed ID: 7498001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
    Kateera F; Nsobya SL; Tukwasibwe S; Hakizimana E; Mutesa L; Mens PF; Grobusch MP; van Vugt M; Kumar N
    Acta Trop; 2016 Dec; 164():329-336. PubMed ID: 27647575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amodiaquine and sulfadoxine-pyrimethamine as treatment for chloroquine-resistant Plasmodium falciparum in Rwanda.
    Deloron P; Sexton JD; Bugilimfura L; Sezibera C
    Am J Trop Med Hyg; 1988 Mar; 38(2):244-8. PubMed ID: 3281489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan.
    Durrani N; Leslie T; Rahim S; Graham K; Ahmad F; Rowland M
    Trop Med Int Health; 2005 Jun; 10(6):521-9. PubMed ID: 15941414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations in PFCRT K76T do not correlate with sulfadoxine-pyrimethamine-amodiaquine failure in Pikine, Senegal.
    Sarr O; Ahouidi AD; Ly O; Daily JP; Ndiaye D; Ndir O; Mboup S; Wirth DF
    Parasitol Res; 2008 Sep; 103(4):765-9. PubMed ID: 18523801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic efficacy of chloroquine or amodiaquine in combination with sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Papua New Guinea.
    Jayatilaka KD; Taviri J; Kemiki A; Hwaihwanje I; Bulungol P
    P N G Med J; 2003; 46(3-4):125-34. PubMed ID: 16454394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy of uncomplicated falciparum malaria: a randomized trial comparing artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone in Irian Jaya, Indonesia.
    Tjitra E; Suprianto S; Currie BJ; Morris PS; Saunders JR; Anstey NM
    Am J Trop Med Hyg; 2001 Oct; 65(4):309-17. PubMed ID: 11693875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of increasing rates of treatment failure by combining sulfadoxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malaria.
    Dorsey G; Vlahos J; Kamya MR; Staedke SG; Rosenthal PJ
    J Infect Dis; 2003 Oct; 188(8):1231-8. PubMed ID: 14551894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Falciparum malaria fully cleared by amodiaquine, pyrimethamine-sulfadoxine and pyrimethamine-sulfalene in areas of chloroquine resistance in Dodoma, Tanzania.
    Irare SG; Lemnge MM; Mhina JI
    Trop Geogr Med; 1991 Oct; 43(4):352-6. PubMed ID: 1812599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific and nonspecific responses to Plasmodium falciparum blood-stage parasites and observations on the gametocytemia in schoolchildren living in a malaria-endemic area of Mozambique.
    Hogh B; Thompson R; Hetzel C; Fleck SL; Kruse NA; Jones I; Dgedge M; Barreto J; Sinden RE
    Am J Trop Med Hyg; 1995 Jan; 52(1):50-9. PubMed ID: 7856825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chloroquine, sulfadoxine-pyrimethamine and amodiaquine efficacy for the treatment of uncomplicated Plasmodium falciparum malaria in Upper Nile, south Sudan.
    van den Broek IV; Gatkoi T; Lowoko B; Nzila A; Ochong E; Keus K
    Trans R Soc Trop Med Hyg; 2003; 97(2):229-35. PubMed ID: 14584383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of drug level measurement and parasite genotyping data for improved assessment of amodiaquine and sulfadoxine-pyrimethamine efficacies in treating Plasmodium falciparum malaria in Gabonese children.
    Aubouy A; Bakary M; Keundjian A; Mbomat B; Makita JR; Migot-Nabias F; Cot M; Le Bras J; Deloron P
    Antimicrob Agents Chemother; 2003 Jan; 47(1):231-7. PubMed ID: 12499196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved efficacy with amodiaquine instead of chloroquine in sulfadoxine/pyrimethamine combination treatment of falciparum malaria in Uganda: experience with fixed-dose formulation.
    Obua C; Gustafsson LL; Aguttu C; Anokbonggo WW; Ogwal-Okeng JW; Chiria J; Hellgren U
    Acta Trop; 2006 Nov; 100(1-2):142-50. PubMed ID: 17113554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial.
    Staedke SG; Kamya MR; Dorsey G; Gasasira A; Ndeezi G; Charlebois ED; Rosenthal PJ
    Lancet; 2001 Aug; 358(9279):368-74. PubMed ID: 11502317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?
    Sibley CH; Hyde JE; Sims PF; Plowe CV; Kublin JG; Mberu EK; Cowman AF; Winstanley PA; Watkins WM; Nzila AM
    Trends Parasitol; 2001 Dec; 17(12):582-8. PubMed ID: 11756042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Plasmodium falciparum drug resistance in the Congo. Evaluation of surveys carried out from 1985 to 1989].
    Carme B; Moudzeo H; Mbitsi A; Sathounkazi C; Ndounga M; Brandicourt O; Gay F; Le Bras J; Gentilini M
    Bull Soc Pathol Exot; 1990; 83(2):228-41. PubMed ID: 2208453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy of the amodiaquine+sulfadoxine-pyrimethamine combination and of chloroquine for the treatment of malaria in Córdoba, Colombia, 2006].
    Pérez MA; Cortés LJ; Guerra AP; Knudson A; Usta C; Nicholls RS
    Biomedica; 2008 Mar; 28(1):148-59. PubMed ID: 18645670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union.
    Tall A; Rabarijaona LP; Robert V; Bedja SA; Ariey F; Randrianarivelojosia M
    Acta Trop; 2007 Jun; 102(3):176-81. PubMed ID: 17568549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.